The present study suggests that up‐regulation of SMYD2 expression in cisplatin‐induced CKD may promote apoptosis of renal tubular epithelial cells and accelerate the process of renal injury through NF‐κB activation. Here, NFKB1 is linked to chronic kidney disease.